Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eaton Vance Ohio Municipal Income Trust (NQ:EVO)

3.950 -0.130 (-3.19%)
Streaming Delayed Price Updated: 11:29 AM EDT, May 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Eaton Vance Ohio Municipal Income Trust

< Previous 1 2 3 4 5 6 7 8 9 Next >
Evotec Receives $ 2.5 m Grant to Generate Next Generation Tuberculosis Treatments
Via ACCESS Newswire
Earnings Scheduled For May 6, 2025
Via Benzinga
Evotec SE Reports Q1 2025 results: Paving the Way for 2025 Growth in Soft Market Environment
Via ACCESS Newswire
Earnings Preview: Evotec
Via Benzinga
Evotec SE to Announce Results for the First Quarter 2025 on 6 May 2025
Via ACCESS Newswire
Evotec Announces Significant Progress in Strategic Protein Degradation Collaboration with Bristol Myers Squibb
Via ACCESS Newswire
Evotec Announces Key Progress in Neuroscience Collaboration with Bristol Myers Squibb
Via ACCESS Newswire
Evotec Announces Change in Management Board
Via ACCESS Newswire
Evotec Announces Change in Management Board
Via ACCESSWIRE
Comment on Withdrawn Non-Binding Offer
Via ACCESSWIRE
uniQure, Hertz Global, Eli Lilly And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Earnings Scheduled For April 17, 2025
Via Benzinga
Evotec SE Unveils New Strategy and Provides 2025 Guidance Bolstered by Strong Q4 2024 Results
Via ACCESS Newswire
Insights into Evotec's Upcoming Earnings
Via Benzinga
Evotec Announces Sale of API Manufacturing Facility to Monacum Partners
Via ACCESSWIRE
Evotec SE to Announce Results for Financial Year 2024 on 17 April 2025
Via ACCESS Newswire
Evotec Receives Grant from Korean Government to Develop Novel Antibody-based Treatments for Lung Diseases
Via ACCESS Newswire
Ingles Markets, Tesla And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Via Benzinga
Evotec SE announces first projects for LAB eN(2) drug discovery accelerator with Novo Nordisk
Via ACCESSWIRE
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Halozyme Withdraws Evotec Bid After Rebuff, Reaffirms Strong Growth Outlook
Halozyme stock rises after withdrawing its €2B acquisition offer for Evotec, while reaffirming strong growth outlook for 2024. 
Via Benzinga
Intuit Issues Weak Forecast, Joins Reddit And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Via Benzinga
Large Pharma Partner Halozyme Therapeutics Offers To Acquire Germany-Based Evotec For ~$2 Billion
Halozyme offers to acquire Evotec for €11.00 per share, boosting Evotec's value to €2 billion. The merger aims to enhance Halozyme's revenue growth and portfolio. 
Via Benzinga
Comment on Media Report
Via ACCESSWIRE
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Private Equity Triton Partners Takes Around 10% Stake In Evotec, Reportedly Mulls Potential Takeover Deal
Evotec sees a 13.3% stock rise amid reports of Triton Partners eyeing a potential buyout after acquiring a 9.99% stake in the company. 
Via Benzinga
Exact Sciences Posts Downbeat Results, Joins Super Micro Computer, Honda Motor And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Evotec SE Reports 9M 2024 Results: Strategic Progress and Successful Expansion Amid Challenging Market Conditions
Via ACCESSWIRE
Integra LifeSciences Posts Upbeat Results, Joins Air Transport Services, Freshpet, Yum China And Other Big Stocks Moving Higher On Monday
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.